Type 2 Diabetes clinical trials
Showing 351–391 of 391 active trials. Describe your situation to see which ones you may be eligible for.
- MObile Support Adapted to Individual Contexts
- GLP_1 RA Ultrasound Study
- Scaling Telehealth Models to Improve Co-morbid Diabetes and Hypertension in Immigrant Populations (Phase II)
- Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes
- The BEET Diabetes Feasibility Trial
- Food and Resources Expanded to Support Health and Type 2 Diabetes
- Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
- MTM2MTG Pilot Ancillary Study
- Evaluate the Efficacy of an Oral Health Behavioral Intervention in People With Diabetes
- Evaluating the Effectiveness of a Multi-level Health-Related Social Needs Initiative
- Feasibility of Improving Glycemia With Heat Therapy to Prevent AD
- Physiologic and Functional Adaptations of Insulin Sensitive Tissues
- Virtual Lifestyle Intervention for Weight Management and Cardiovascular Heal
- MetSense Pilot and Feasibility
- Truway Diagnostic Tools in Primary Care
- Promoting Nutrition Security and Chronic Disease Management Through a Produce Prescription Program
- Evaluation of a Primary Care Based Lifestyle Medicine Clinic at UAB
- Meals for Me: Drop Shipment Versus Personally-delivered Meals for Diabetes Management
- Glycemic Excursion Minimization (GEM) to Outshine Health Disparities
- A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Participants With Type 2 Diabetes Mellitus
- A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers
- A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM
- Renal Mechanism of SGLT2 Inhibition
- Time-Restricted Eating for Type II Diabetes: TRE-T2D
- Depression in Youth Onset Type 2 Diabetes
- A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D)
- A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus
- A Study of LY3938577 in Participants With Type 2 Diabetes Previously Treated With Basal Insulin
- A Study of DII235 in Adults With Elevated Lipoprotein(a)
- Remotely Delivered Resistance Training for Cardiometabolic Health Among Black Women
- Mobile Regulation of Craving Training (mROC-T) to Improve Dietary Intake in Rural Adolescent Girls
- Diabetes Prevention in Hispanic Adults Using Constant Glucose Monitors
- Health Without Barriers/Salud Sin Barreras- Northern Colorado
- Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
- The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System
- Developing and Testing a Self-Compassion Tool Kit to Improve the Care of Individuals With Type 2 Diabetes
- Promoting Preconception Care and Diabetes Self-Management Among Reproductive-Aged Women With Diabetes
- Enhancing Telemedicine for T2D
- Strategies to Improve Well-Being and Diabetes Management
- Care Navigator Support for Younger Latinx Adults With Type 2 Diabetes
- A Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.